4
Changes in Ownership
DBV Technologies S.A. Filed Acc 0001209191-23-045641
Chief Medical Officer sold 2,261 shares at an average $3.02 ($6,821)
- Chief Medical Officer acquired 27,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mohideen Pharis Chief Medical Officer | 2022-07-29 | Grant or award | +10,000 | 34,200 | D | ||
| Mohideen Pharis Chief Medical Officer | 2022-11-21 | Grant or award | +17,500 | 51,700 | D | ||
| Mohideen Pharis Chief Medical Officer | 2022-11-24 | Sale | −1,792 | $2.88 | $5,161 | 49,908 | D |
| Mohideen Pharis Chief Medical Officer | 2023-05-24 | Sale | −469 | $3.54 | $1,660 | 49,439 | D |
| Derivatives | |||||||
| Mohideen Pharis Chief Medical Officer | 2022-07-29 | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | D | ||
| Mohideen Pharis Chief Medical Officer | 2022-11-21 | Grant or award · Employee Stock Option (right to buy) | +115,000 | 115,000 | D | ||
| Open-market sales · 2,261 sh · avg $3.02 · $6,821 | |||||||
Loading xslF345X05/doc4.xml…